Compositions for detection of a target nucleic acid sequence

• US 20070099205A1
• Filed: 05/25/2006
• Published: 05/03/2007
• Est. Priority Date: 10/29/1999
• Status: Active Grant

• Current Assignee: Hologic Incorporated
• Original Assignee: Stratagene California
• Inventors: Sorge, Joseph
• Granted Patent: US 7,794,935 B2
• Time in Patent Office: Days
• US Class Current: 435/6.1
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6844 Nucleic acid amplification reactions
• CPC Class Codes: C12Q 2525/161 incorporating target specific and non-target specific sites
• CPC Class Codes: C12Q 2531/101 Linear amplification, i.e. non exponential
• CPC Class Codes: C12Q 2537/149 Sequential reactions

Abstract

The invention relates to compositions for generating a signal indicative of the presence of a target nucleic acid in a sample. The compositions include a reverse transcriptase, a nuclease, an upstream primer and downstream probe.

Claims

1. A composition comprising a reverse transcriptase, a cleavage means, a first oligonucleotide and a second oligonucleotide.

2. The composition of claim 1, wherein said cleavage means comprises a 5′

nuclease.

3. The composition of claim 2, wherein said 5′

nuclease is a FEN-1 nuclease.

4. The composition of claim 3, wherein said FEN-1 nuclease is a flap specific nuclease.

5. The composition of claim 3, wherein said FEN-1 nuclease is thermostable.

6. The composition of claim 1, wherein said reverse transcriptase is thermostable.

7. The composition of claim 1, wherein the 3′

nucleotide of said second oligonucleotide has a blocking group.

8. The composition of claim 1, wherein the second oligonucleotide comprises at least one labeled moiety capable of providing a signal.

9. The composition of claim 1, wherein the second oligonucleotide comprises a pair of interactive signal generating labeled moieties.

10. The composition of claim 9, wherein said pair of interactive signal generating moieties comprises a quencher moiety and a fluorescent moiety.

11. The composition of claim 10, wherein at least one member of the pair of interactive signal generating labeled moieties is operatively coupled to the 5′

region of the second oligonucleotide.

12. The composition of claim 8, wherein the at least one labeled moiety is operatively coupled to the 5′

region of the second oligonucleotide.

13. A kit comprising a composition of claim 1 and packaging materials therefore.

14. The kit of claim 13, wherein said cleavage means comprises a 5′

nuclease.

15. The kit of claim 14, wherein said 5′

nuclease is a FEN-1 nuclease.

16. The kit of claim 13, wherein the 3′

nucleotide of said second oligonucleotide has a blocking group.

17. The kit of claim 13, wherein the second oligonucleotide comprises at least one labeled moiety capable of providing a signal.

18. The kit of claim 13, wherein the second oligonucleotide comprises a pair of interactive signal generating labeled moieties.

19. The kit of claim 18, wherein said pair of interactive signal generating moieties comprises a quencher moiety and a fluorescent moiety.

20. The kit of claim 18, wherein at least one member of the pair of interactive signal generating labeled moieties is operatively coupled to the 5′

flap of the second oligonucleotide.

21. The kit of claim 17, wherein the at least one labeled moiety is operatively coupled to the 5′

flap of the second oligonucleotide.

22. The composition of claim 1, further comprising a target nucleic acid.

23. A composition comprising:

(i) a target nucleic acid, which comprises in 3′

to 5′

order a first region, an extension region, and a second region;

(ii) a first oligonucleotide that is at least partially complementary to said first region of said target nucleic acid;

(iii) a second oligonucleotide comprising a 5′

region and a 3′

region, wherein said 3′

region is at least partially complementary to said second region of said target nucleic acid and wherein said 5′

region is not complementary to said target nucleic acid;

(iv) a reverse transcriptase; and

(v) a cleavage means.

24. A kit comprising the composition of claim 23 and packaging materials therefore.

25. A composition comprising:

(i) a target nucleic acid, which comprises in 3′

to 5′

order a first region, an extension region, and a second region;

(ii) a first oligonucleotide that is at least partially complementary to said first region of said target nucleic acid;

(iii) a second oligonucleotides corresponding to said target nucleic acids, said second oligonucleotides comprising a 5′

region and a 3′

region, wherein said 3′

region is at least partially complementary to said second region of said target nucleic acid and wherein said 5′

region is at least partially complementary to a region that may be upstream of, downstream of, or comprise said first region of said target nucleic acid;

(iv) a reverse transcriptase; and

(v) a cleavage means.

26. A kit comprising the composition of claim 25 and packaging materials therefore.

27. A composition comprising:

(i) a template nucleic acid, which comprises in 3′

to 5′

order a first region, an extension region, and a second region;

(ii) a first oligonucleotide that is at least partially complementary to said first region of said target nucleic acid;

(iii) a second oligonucleotide comprising a 5′

region and a 3′

region, wherein said 3′

region is at least partially complementary to said second region of said target nucleic acid and wherein said 5′

region is not complementary to said target nucleic acid;

(iv) a reverse transcriptase; and

(v) a cleavage means.

28. A kit comprising the composition of claim 27 and packaging materials therefore.

29. A composition comprising:

(i) a template nucleic acid, which comprises in 3′

to 5′

order a first region, an extension region, and a second region;

(ii) a first oligonucleotide that is at least partially complementary to said first region of said template nucleic acid;

(iii) a second oligonucleotides corresponding to said template nucleic acids, said second oligonucleotides comprising a 5′

region and a 3′

region, wherein said 3′

region is at least partially complementary to said second region of said template nucleic acid and wherein said 5′

region is at least partially complementary to a region that may be upstream of, downstream of, or comprise said first region of said template nucleic acid;

(iv) a reverse transcriptase; and

(v) a cleavage means.

30. A kit comprising the composition of claim 29 and packaging materials therefore.